Study Shows HoLEP with MOSES 2.0 Saves $747 Per Case Over Standard HoLEP

Holmium laser enucleation of the prostate (HoLEP) has been shown in multiple studies to be the definitive surgery for benign prostatic hyperplasia (BPH). It is size independent, allows for maximum removal of prostate tissue, and has a retreatment rate of about 1% at two decades.

BPH, Lithotripsy

How Starting a Small City Urology Clinic with the MOSES Holmium Laser Changed a Community – and My Career

After using a Lumenis holmium laser with MOSES at my previous hospital in California and attending additional HoLEP training in Cambridge, England, I was so pleased and confident with the outcomes that I made MOSES technology a requirement for my next career move.


Mentoring Through HoLEPs Learning Curve

For treatment of benign prostatic hyperplasia (BPH), transurethral Holmium Laser Enucleation of the Prostate (HoLEP) has emerged as the new gold standard. Compared to other familiar BPH procedures, HoLEP has lower morbidity, less blood loss, more comfortable recovery, a shorter hospital stay, less time with a catheter, and lower retreatment rates.

Subscribe to Our Newsletter

You have Successfully Subscribed!